Global coalition calls for urgent action by the G20 to address growing international health challenges

London, 28 June 2017

Today, 33 leading Global Health organisations and members of National Parliaments have issued an open letter to G20 Heads of State, calling for them to increase the prioritisation of health by the G20, and establish the G20 as a permanent global health policy forum.

The letter calls for Heads of State to continue the strong focus on R&D to address critical challenges like emerging and drug-resistant infectious diseases.
The signatories also encourage G20 Leaders to include the conclusions of the inaugural Health Minister’s declaration in next week’s declaration of the G20 Heads of State Communique in Hamburg.

Given the growing risk to humanity the letter urges leaders to increase financial and political support for global health R&D, and to encourage private sector and philanthropic organisations to accelerate addressing anti-microbial resistance, pandemic preparedness and poverty related neglected diseases.

“I fully endorse the G20 Leaders’ decision to place Global Health Innovation on the G20 agenda. We must prioritise AMR R&D in key pathogens – such as HIV, TB, Malaria, and NTDs – moving forward.”

Jeremy Lefroy MP, UK Member of Parliament, Chair of the Parliamentary Network on the World Bank and International Monetary Fund

“The G20 gives developing countries more power and coordination in managing the global economy. We welcome their decision to place Global Health Innovation and critical issues like antimicrobial resistance in malaria, TB and HIV on the agenda. In doing so, the G20 is making a powerful statement that they intend to address the full range of issues that affect world economies – a critical step forward for global health and wealth.”

David Reddy, CEO MMV

“At a time when global health challenges—like antimicrobial resistance and emerging infectious diseases—are on the rise, it is critical that G20 nations join together to make sure we have the vaccines, medicines, and other tools in hand to address current as well as future health crises.”

Jamie Bay Nishi, Director, Global Health Technologies Coalition

“The medical technology industry is committed to the fight against AMR, which is a global public health issue in need of global leadership. MedTech Europe would welcome G20 support in the uptake of medical technologies that have a great potential to prevent the misuse and overuse of antibiotics throughout the patient pathway.”

MedTech Europe

Chancellor Angela Merkel has put global health at the heart of her government’s G20 Presidency. This momentum must be built on, with the G20 becoming a permanent forum for ministerial dialogue and action on global health policy, starting with next year’s Argentinian presidency.

Notes to Editor:

Further information about our Global Health Innovation Event:

  • The “Research for Impact and the G20: How can global health innovation drive sustainable development?” roundtable event, held on Friday 28th April 2017 at the Quadriga Forum in Berlin, Germany was organized by Sovereign Strategy and co-hosted with the following organizations: the Global Alliance for TB Drug Development (TB Alliance), Medicines for Malaria Venture (MMV), the Sabin Vaccine Institute, the Coalition for Epidemic Preparedness Innovations (CEPI), PATH (Program for Appropriate Technology in Health), the Global Health Technologies Coalition (GHTC), the Global Health Innovative Technology (GHIT) Fund, UNITAID and CARB-X.
  • The one-day roundtable event involved opening and closing speeches, two sessions of moderated roundtable discussions, presentations on the G20 priority foci of Antimicrobial Resistance (AMR) and pandemic preparedness, the B20 and its health initiative as well as the current project, its “Call to Action” (CTA) output document and discussions on how to carry it forward.
  • The stated objective was to create a platform for cooperation and policy advocacy for an open and unique coalition of organizations following the declaration of the G20 Health Ministers and leading up to the G20 Hamburg Summit.
  • The roundtable discussions are summarised in the Rapporteur’s Report.
  • Over 100 public and private health stakeholders backed four recommendations agreed the roundtable in a “Call to Action”, published ahead of the G20 Health Ministers summit

Sovereign Strategy’s role in bringing the community together:

  • On behalf of – and alongside – the co-hosts of this event, Sovereign Strategy has developed, managed and implemented this multi-stakeholder project over a number of months in order to bring global health advocates together to discuss areas of high importance both to the G20 and to the wider international community. Sovereign sees this multi-sectoral initiative as the beginning, rather than the culmination, of a critical dialogue. Sovereign Strategy is a leading independent public affairs and communications consultancy headquartered in Brussels and London and has been working in global development for a number of years specialising in areas such as global health and sustainable urbanisation.